Targeted Therapy (Match EAY131)

Description

Molecular Analysis for Therapy Choice (MATCH)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, lymphoma, and myeloma

This trial is available at multiple Sutter Locations. Please contact one of the following about Study Match EAY 131

San Francisco: ClinicalResearch@sutterhealth.org

Palo Alto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org

East Bay: James Nasman NasmanJ@sutterhealth.org and Vivian Leong, RN Leongv@sutterhealth.org

Sacramento: Isabel Rodrigues-Fong Rodrigi@sutterhealth.org and Kirsten Babski babskik@sutterhealth.org

Modesto: Delia Massone MassonD@sutterhealth.org and Adrienne Palos PalosA@sutterhealth.org

Solano-Vallejo Cancer Center: Stephanie Gonzales gonzals@sutterhealth.org

View study details on ClinicalTrials.gov

Principal Investigator

Edmund W. Tai, M.D.

Recruitment Status

Active, Recruiting

Start Date

February 01, 2017

Related Studies

Advance Care Planning Practices in Caring for Vulnerable Elders with Multiple Chronic Conditions

To examine the impact of the palliative care program on the patterns of ACP documentation in EHR of patients with multiple chronic conditions.

Investigator: Ellis C. Dillon, Ph.D.

Breast Cancer Chemoprevention in Primary Care at Geisinger

Identify PCPs’ awareness of breast cancer risk assessment and breast cancer chemoprevention knowledge, and identify perceived barriers and clinic solutions.

Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator

Breast Tumor and Blood markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up

This study seeks to analyze of DNA and RNA isolated from donor tissues for molecular, biochemical, immunological and/or histopathological analysis.

Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions

Our objective is to examine “coverage, price, and reimbursement” for multigene tests broadly and for cancer-related indications.

Investigator: Su-Ying Liang, Ph.D.

Impact of COVID-19 on Cancer Care Management

Study will enhance understanding of cancer care management due to COVID-19.

Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH

Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts

To describe and explain variations in Lynch syndrome (LS) screening implementation across healthcare systems and create a toolkit for implementing LS screening.

Investigators: External PI, Principal Investigator, Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.

Improving Cancer Care

Project will provide information about referrals to palliative care and way to enhance goals of care discussions for patients diagnosed with stage IV cancer.

Investigators: Ellis C. Dillon, Ph.D., Su-Ying Liang, Ph.D., Harold (Hal) Luft, Ph.D.

Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women

The goal of this project is to document incidence and risk factors for lung cancer by smoking status, among AANHPIs, focusing especially on female never smokers.

Investigators: External PI, Principal Investigator, Harold (Hal) Luft, Ph.D., Su-Ying Liang, Ph.D.

Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)

Provide insights into preventive services for lung cancer. This research will contribute to the concurrent progress in lung cancer screening with LDCT.

Investigators: Dorothy Hung, Ph.D., M.A., MPH, Jiang Li, Ph.D., MPH

Using Electronic Health Records to Understand Pathways of Breast Cancer Screening and Care

To examine how EHR data can expand understanding of breast cancer pathways--screening to dx and tx.

We've expanded your view